β-Carotene as enhancer of cell transforming activity of powerful carcinogens and cigarette-smoke condensate on BALB/c 3T3 cells in vitro

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 440, Issue 1, 1999, Pages 83-90

  Perocco, P ^a   Paolini, M ^a   Mazzullo, M ^a   Biagi, G L ^a   Cantelli Forti, G ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Univ T   (United States)

Author keywords

Carotene; BALB c 3T3 cell; Cell transformation; Environmental risk; Lung cancer

Indexed keywords

3 METHYLCHOLANTHRENE; BENZO[A]PYRENE; BETA CAROTENE; TOBACCO SMOKE; XENOBIOTIC AGENT;

ARTICLE; CARCINOGENESIS; CELL TRANSFORMATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; ENVIRONMENT; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; RISK FACTOR;

3T3 CELLS; ANIMALS; BENZO(A)PYRENE; BETA CAROTENE; CARCINOGENS; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CLONE CELLS; COCARCINOGENESIS; DRUG SYNERGISM; METHYLCHOLANTHRENE; MICE; MICE, INBRED BALB C; SMOKE;

EID: 0033064236     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(99)00009-1     Document Type: Article

References (24)

1. Rock L. Carotenoids: biology and treatment. Pharmacol. Ther. 75:1997;185-197.
2. Stahl W., Sies H. Physical quenching of singlet oxygen and cis-trans isomerization of carotenoids. Ann. N.Y. Acad Sci. 691:1993;10-19.
3. Omaye S.T., Krinsky N.I., Kagan V.E., Mayne S.T., Liebler D.C., Bidlack W.R. β-carotene: friend or foe? Fundam. Appl. Toxicol. 40:1997;163-174.
4. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330:1994;1029-1035.
5. Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A., Keogh J.P., Meyskens F.L., Valanis B., Williams J.H., Barnhart S., Hammar S. Effect of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 334:1996;1150-1155.
6. Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A., Keogh J.P., Meyskens F.L., Valanis B., Williams J.H., Barnhart S., Cherniack M.G., Brodkin C.A., Hammar S. Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial. J. Natl. Cancer Inst. 88:1996;1550-1558.
7. Rowe P.M. CARET and ATBC refine conclusions about β-carotene. Lancet. 348:1996;1369.
8. Hinds T.S., West W.L., Knight E.M. Carotenoids and retinoids: a review of research, clinical, and public health applications. Ther. Rev. 37:1997;551-558.
9. Azuine M.A., Goswami U.C., Kayal J.J., Bhide S.V. Antimutagenic and anticarcinogenic effects of carotenoids and dietary polin oil. Nutr. Cancer. 17:1992;287-295.
10. Brockman H.E., Stack H.F., Waters M.D. Antimutagenicity profile of some natural substances. Mutat. Res. 267:1992;157-172.
11. Rauscher R., Edenharder R., Platt K.L. In vitro antimutagenic and in vivo anticlastogenic effects of carotenoids and solvent extracts from fruit and vegetables rich in carotenoids. Mutat. Res. 413:1998;129-142.
12. IARC/NCI/EPA Working Group Cellular and molecular mechanisms of cell transformation and standardization of transformation assays of established cell lines for the prediction of carcinogenic chemicals: overview and recommended protocols. Cancer Res. 45:1985;2395-2399.
13. L.M. Schechtman, BALB/c 3T3 cell transformation: protocols, problems and improvements, in: T. Kakunaga, H. Yamasaki (Eds.), Transformation Assay of Established Cell Lines: Mechanisms and Application, IARC Scientific Publications, 67, International Agency for Research on Cancer, Lyon, 1985, pp. 165-184.
14. Lubet R.A., Kouri R.E., Curren R.A., Putman D.L., Schechtman L.M. Induction of mutagenesis and transformation in BALB/c 3T3 clone A31-1 cells by diverse chemical carcinogens. Environ. Mol. Mutagen. 16:1990;13-20.
15. Bürki K., Bresnick E. Early morphologic alterations in mouse skin after topical application of 3-methylcholathrene and its metabolites. J. Natl. Cancer Inst. 55:1975;171-175.
16. George J.D., Manson J.M. Strain-dependent differences in the metabolism of 3-methylcholanthrene by maternal, placental, and fetal tissues of C57BL/6J and DBA/2J mice. Cancer Res. 46:1986;5671-5675.
17. DiGiovanni J., Diamond L., Prichett W.P., Fisher E.P., Harvey R.G. Tumor-initiating activity of the 9,10-dihydrodiol- and 9,10-dihydrodiol-7,8-epoxide of 3-methylcholanthrene in SENCAR mice. Cancer Lett. 28:1985;223-228.
18. Gelboin H.V. Benzo(a)pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol. Rev. 60:1980;1107-1166.
19. Paolini M., Pozzetti L., Pedulli G.F., Cipollone M., Mesirca R., Cantelli-Forti G. Paramagnetic resonance in detecting carcinogenic risk from cytochrome P450 overexpression. J. Invest. Med. 44:1996;470-473.
20. Puntarulo S., Cederbaum A.I. Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes. Free Radic. Biol. Med. 24:1998;1324-1330.
21. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man, 38, Tobacco Smoking, International Agency for Research on Cancer, Lyon, 1986.
22. Anttila S., Hietanen H., Vainio H., Camus A.M., Gelboin H.V., Park S.S., Heikkila L., Karjalainen A., Batsch H. Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P450IA in lung cancer patients. Int. J. Cancer. 47:1991;681-685.
23. 32P -postlabeling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokers Carcinogenesis. 12:1991;1301-1305.
24. E. Buiatti, An overview of recent results of chemoprevention trials, in: C. Maltoni, M. Soffritti, W. Davis (Eds.), The Scientific Bases of Cancer Chemoprevention, Elsevier, Amsterdam, 1996, pp. 257-266.